Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Christoph Baldow · SciRah

Researcher profile · Semantic Scholar

Christoph Baldow

Share profile

Christoph Baldow — researcher profile on SciRah

h-index: 7
Works: 19
Citations: 284

Most-cited papers

Drug target prioritization by perturbed gene expression and network information
Zerrin Işık, Christoph Baldow, C. Cannistraci, Michael Schroeder
2015Scientific Reports112 citations Open access
Semantic Scholar
Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: a simulation study based on phase III trial data
A. C. Fassoni, Christoph Baldow, I. Roeder, I. Glauche
2018Haematologica67 citations Open access
Semantic Scholar
Quantitative prediction of long-term molecular response in TKI-treated CML – Lessons from an imatinib versus dasatinib comparison
I. Glauche, M. Kuhn, Christoph Baldow, P. Schulze +5 more
2018Scientific Reports25 citations Open access
Semantic Scholar
Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CML
T. Hähnel, Christoph Baldow, J. Guilhot, F. Guilhot +9 more
2020Cancer Research22 citations Open access
Semantic Scholar
Integration of mathematical model predictions into routine workflows to support clinical decision making in haematology
Katja Hoffmann, Katja Cazemier, Christoph Baldow, Silvio Schuster +13 more
2020BMC Medical Informatics and Decision Making14 citations Open access
Semantic Scholar
Model Based Analysis of Clonal Developments Allows for Early Detection of Monoclonal Conversion and Leukemia
Christoph Baldow, L. Thielecke, I. Glauche
2016PLoS ONE12 citations Open access
Semantic Scholar
Modelling of immune response in chronic myeloid leukemia patients suggests potential for treatment reduction prior to cessation
Elena Karg, Christoph Baldow, T. Zerjatke, Richard E. Clark +3 more
2022Frontiers in Oncology8 citations Open access
Semantic Scholar
Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CML
T. Hähnel, Christoph Baldow, J. Guilhot, F. Guilhot +10 more
20217 citations
Semantic Scholar
MAGPIE: Simplifying access and execution of computational models in the life sciences
Christoph Baldow, Sebastian Salentin, Michael Schroeder, Ingo Roeder +1 more
2017PLoS Comput. Biol.5 citations Open access
Semantic Scholar
How to predict relapse in leukemia using time series data: A comparative in silico study
Helene Hoffmann, Christoph Baldow, T. Zerjatke, Andrea Gottschalk +6 more
2020medRxiv4 citations Open access
Semantic Scholar
Clonal reconstruction from co-occurrence of vector integration sites accurately quantifies expanding clones in vivo
Sebastian Wagner, Christoph Baldow, A. Calabria, L. Rudilosso +4 more
2022Nature Communications3 citations Open access
Semantic Scholar
Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy
Rick Proschmann, Christoph Baldow, Tino Rothe, M. Suttorp +6 more
2017Haematologica2 citations Open access
Semantic Scholar
Inferring immunological control mechanisms from TKI dose alterations in CML patients
T. Hähnel, Christoph Baldow, A. C. Fassoni, J. Guilhot +9 more
2019bioRxiv1 citations Open access
Semantic Scholar
A New Computational Method to Predict Long-Term Minimal Residual Disease and Molecular Relapse after TKI-Cessation in CML
I. Glauche, Hendrik Liebscher, Christoph Baldow, M. Kuhn +12 more
20161 citations
Semantic Scholar
Model-Based Characterization of the Molecular Response Dynamics of Tyrosine Kinase Inhibitor (TKI)-Treated CML Patients – a Comparison of Imatinib and Dasatinib First-Line Therapy
I. Glauche, Christoph Baldow, S. Fröhlich, P. Schulze +4 more
20141 citations
Semantic Scholar
Clonal reconstruction from co-occurrence of vector integration sites allows accurate quantification of expanding clones in vivo
Sebastian Wagner, Christoph Baldow, A. Calabria, L. Rudilosso +4 more
2021bioRxiv0 citations Open access
Semantic Scholar
Mathematical modelling of megakaryopoiesis in Mpl-deficient and continuously thrombopoietin-stimulated mice points to an unknown control mechanism
H. Diebner, A. Gottschalk, Christoph Baldow, M. Klose +1 more
2020bioRxiv0 citations Open access
Semantic Scholar
Reconstruction of hierarchical differentiation processes based on the temporal clonal readout in distinct hematopoietic lineages
I. Glauche, Christoph Baldow
20170 citations Open access
Semantic Scholar
A mathematical modeling approach towards immunological control of minimal residual disease in CML patients
I. Glauche, A. C. Fassoni, T. Haehnel, Christoph Baldow +1 more
20170 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

I. Glauche×17
Invite
I. Glauche — researcher profile on SciRah
I. Roeder×9
Invite
I. Roeder — researcher profile on SciRah
A. C. Fassoni×6
Invite
A. C. Fassoni — researcher profile on SciRah
S. Dulucq×4
Invite
S. Dulucq — researcher profile on SciRah

×4

Invite

F. Mahon — researcher profile on SciRah

Invite

P. Schulze — researcher profile on SciRah

Invite

T. Hähnel — researcher profile on SciRah

Invite

J. Guilhot — researcher profile on SciRah

Invite

F. Guilhot — researcher profile on SciRah

Invite

S. Saussele — researcher profile on SciRah

Invite

S. Mustjoki — researcher profile on SciRah

Invite

S. Jilg — researcher profile on SciRah